Suppr超能文献

毛细支气管炎住院患儿细菌感染的患病率和危险因素。

Prevalence of and Risks for Bacterial Infections in Hospitalized Children With Bronchiolitis.

机构信息

Divisions of Critical Care.

Department of Pediatrics, Navy Medicine Readiness and Training Command, San Diego, California.

出版信息

Hosp Pediatr. 2024 Aug 1;14(8):603-611. doi: 10.1542/hpeds.2023-007549.

Abstract

BACKGROUND AND OBJECTIVES

Viral bronchiolitis is a common pediatric illness. Treatment is supportive; however, some children have concurrent serious bacterial infections (cSBIs) requiring antibiotics. Identifying children with cSBI is challenging and may lead to unnecessary treatment. Improved understanding of the prevalence of and risk factors for cSBI are needed to guide treatment. We sought to determine the prevalence of cSBI and identify factors associated with cSBI in children hospitalized with bronchiolitis.

METHODS

We performed a retrospective cohort study of children <2 years old hospitalized with bronchiolitis at a free-standing children's hospital from 2012 to 2019 identified by International Classification of Diseases codes. cSBI was defined as bacteremia, urinary tract infection, meningitis, or pneumonia. Risk factors for cSBI were identified using logistic regression.

RESULTS

We identified 7871 admissions for bronchiolitis. At least 1 cSBI occurred in 4.2% of these admissions; with 3.5% meeting our bacterial pneumonia definition, 0.4% bacteremia, 0.3% urinary tract infection, and 0.02% meningitis. cSBI were more likely to occur in children with invasive mechanical ventilation (odds ratio [OR] 2.53, 95% confidence interval [CI] 1.78-3.63), a C-reactive protein ≥4 mg/dL (OR 2.20, 95% CI 1.47-3.32), a concurrent complex chronic condition (OR 1.67, 95% CI 1.22-2.25) or admission to the PICU (OR 1.46, 95% CI 1.02-2.07).

CONCLUSIONS

cSBI is uncommon among children hospitalized with bronchiolitis, with pneumonia being the most common cSBI. Invasive mechanical ventilation, elevated C-reactive protein, presence of complex chronic conditions, and PICU admission were associated with an increased risk of cSBI.

摘要

背景和目的

病毒性细支气管炎是一种常见的儿科疾病。治疗方法为支持性治疗;然而,有些儿童并发严重细菌感染(cSBI),需要使用抗生素。识别并发 cSBI 的儿童具有挑战性,可能导致不必要的治疗。为了指导治疗,需要更好地了解 cSBI 的患病率和危险因素。我们旨在确定患有细支气管炎住院儿童中 cSBI 的患病率,并确定与 cSBI 相关的因素。

方法

我们对 2012 年至 2019 年期间在一家独立儿童医院因细支气管炎住院的<2 岁儿童进行了回顾性队列研究,这些儿童的诊断通过国际疾病分类代码确定。cSBI 的定义为菌血症、尿路感染、脑膜炎或肺炎。使用逻辑回归确定 cSBI 的危险因素。

结果

我们确定了 7871 例细支气管炎住院患者。这些患者中至少有 4.2%发生了 cSBI;其中 3.5%符合我们的细菌性肺炎定义,0.4%为菌血症,0.3%为尿路感染,0.02%为脑膜炎。患有侵袭性机械通气(比值比[OR] 2.53,95%置信区间[CI] 1.78-3.63)、C 反应蛋白≥4mg/dL(OR 2.20,95%CI 1.47-3.32)、并发复杂慢性疾病(OR 1.67,95%CI 1.22-2.25)或入住儿科重症监护病房(OR 1.46,95%CI 1.02-2.07)的儿童更有可能发生 cSBI。

结论

患有细支气管炎住院的儿童中 cSBI 并不常见,肺炎是最常见的 cSBI。侵袭性机械通气、C 反应蛋白升高、存在复杂的慢性疾病和入住儿科重症监护病房与 cSBI 的风险增加相关。

相似文献

3
High-flow nasal cannula therapy for infants with bronchiolitis.高流量鼻导管治疗小儿毛细支气管炎
Cochrane Database Syst Rev. 2024 Mar 20;3(3):CD009609. doi: 10.1002/14651858.CD009609.pub3.
5
Antibiotics for exacerbations of asthma.用于哮喘加重期的抗生素
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD002741. doi: 10.1002/14651858.CD002741.pub2.
6
Leukotriene inhibitors for bronchiolitis in infants and young children.用于婴幼儿细支气管炎的白三烯抑制剂
Cochrane Database Syst Rev. 2015 Mar 16;2015(3):CD010636. doi: 10.1002/14651858.CD010636.pub2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验